# Symlin (pramlintide): Dosage, Side Effects & Uses | PepVault

Source: https://pepvault.app/drugs/symlin

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Brand-name drugs](https://pepvault.app/drugs) Symlin

Brand-name drug · amylin analog

# Symlin (pramlintide)

From the FDA label, read Nov 18, 2026 [Published by PepVault](https://pepvault.app/guides/how-we-research)

Symlin is pramlintide from AstraZeneca, a lab-made version of amylin, a hormone the pancreas releases together with insulin after a meal; it is injected from a pen right before each main meal.

FDA approved it as an add-on for people with type 1 or type 2 diabetes who use mealtime insulin and have not reached their blood sugar goal despite the best insulin treatment.

Symlin is being withdrawn: Drugs@FDA lists every Symlin product as discontinued, and the product data on its label gives January 31, 2027 as the end of marketing for both SymlinPen 60 and SymlinPen 120.

- **Active ingredient:** [Pramlintide](https://pepvault.app/peptides/pramlintide)
- **Maker:** AstraZeneca
- **Class:** amylin analog
- **FDA application:** [NDA 021332](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021332), first approved 2005

## What FDA approved it for

The label is strict about who it suits: people under the care of an insulin expert with diabetes educators behind them. It rules out an HbA1c above 9%, severe low blood sugar needing help in the past 6 months, not feeling low blood sugar coming on, a slow-emptying stomach (gastroparesis) and children.

From the label: 12.1 Mechanism of Action; 1 Indications and Usage; 5.1 Patient Selection; Product data (SPL).

## How it is supplied

Symlin’s forms and the doses each one gives, as the label lists them

| Form | Doses |
| --- | --- |
| SymlinPen 60 | 15 mcg, 30 mcg, 45 mcg, 60 mcg |
| SymlinPen 120 | 60 mcg, 120 mcg |

From the label: 3 Dosage Forms and Strengths.

## The label’s dosing schedule

This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.

### Type 2 diabetes, before each main meal

Symlin’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Type 2 diabetes, before each main meal: the steps on the label. Highest dose: 120 mcg before each main meal.

| Dose | When, on the label |
| --- | --- |
| 60 mcg before each main meal | To start, with the mealtime insulin cut by half |
| 120 mcg before each main meal | Once there has been no significant nausea for at least 3 days |

If nausea keeps up at 120 mcg, the label goes back down to 60 mcg.

### Type 1 diabetes, before each main meal

Symlin’s steps as the label lays them out, lowest to highest; each bar’s height is its dose against the top dose. A dashed bar is a step the label allows only if more is needed.

Type 1 diabetes, before each main meal: the steps on the label. Highest dose: 60 mcg before each main meal.

| Dose | When, on the label |
| --- | --- |
| 15 mcg before each main meal | To start, with the mealtime insulin cut by half |
| 30 mcg before each main meal | After at least 3 days without significant nausea |
| 45 mcg before each main meal | After at least 3 more days without significant nausea |
| 60 mcg before each main meal | The top step, reached the same way |

If nausea persists at 45 or 60 mcg, the label steps back to 30 mcg, and if 30 mcg is not tolerated, stopping Symlin is considered.

Each rise waits at least 3 days, to keep nausea down, and blood sugar is checked often, before and after meals and at bedtime, while the dose is set.

From the label: 2.2 Patients with Type 2 Diabetes Using Mealtime Insulin; 2.3 Patients with Type 1 Diabetes; 2.1 Important Considerations Pertaining to SYMLIN and Insulin Dose Adjustments.

## How it’s taken

Each dose goes under the skin of the belly or thigh, not the arm, right before a main meal, meaning one of at least 250 calories or 30 grams of carbohydrate. The spot should be away from where the insulin goes.

Symlin and insulin are always two separate shots and are never mixed in one syringe. When Symlin starts, the mealtime insulin dose is cut by half to lower the chance of a low.

Because Symlin slows how fast the stomach empties, a pill whose quick effect matters (a pain reliever, for example) is taken at least 1 hour before the shot or 2 hours after it.

From the label: 2.4 Administration; 2.1 Important Considerations Pertaining to SYMLIN and Insulin Dose Adjustments; 5.5 Concomitantly Administered Oral Medications.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## If a dose is missed

A missed Symlin dose is not made up: the usual dose is taken before the next main meal.

From the label: 2.4 Administration.

## Storage

Pens not yet in use are kept in the fridge at 36°F to 46°F, out of light, and never frozen. Once in use, a pen can stay in the fridge or at up to 86°F, and is used within 30 days.

From the label: 16 How Supplied/Storage and Handling.

## Side effects and warnings

Adverse reactions with Symlin added to insulin in the long-term placebo-controlled trials in type 1 diabetes (716 on Symlin, 538 on placebo; injuries cover scrapes, bruises, burns, sprains and broken bones). Percent of people.

| Reaction | Placebo | 30 or 60 mcg |
| --- | --- | --- |
| Nausea | 17 | 48 |
| Loss of appetite (anorexia) | 2 | 17 |
| Injuries | 10 | 14 |
| Vomiting | 7 | 11 |
| Joint pain (arthralgia) | 5 | 7 |
| Tiredness | 4 | 7 |
| Allergic reaction | 5 | 6 |
| Dizziness | 4 | 5 |

Nausea came in 48% of people with type 1 diabetes against 17% on placebo, and in 28% against 12% in type 2 diabetes on 120 mcg. The label says nausea is highest at the start and fades with time for most people, and that the slow climb keeps it down.

### The boxed warning

**Boxed warning: “SEVERE HYPOGLYCEMIA”**Used with insulin, Symlin raises the risk of severe low blood sugar, most of all in type 1 diabetes, and when it happens it comes within 3 hours of a shot. The label names careful choice of patients, careful teaching and a lower insulin dose as the ways to cut that risk.

### The other warnings

Its other warnings: a Symlin pen is never shared, even with a new needle; Symlin and insulin are never mixed; it can delay pills taken alongside it; it is not used with medicines that speed up the gut; and it can cause allergic reactions. On its own, without insulin, Symlin does not cause low blood sugar.

From the label: 6.1 Clinical Trial Experience; Boxed Warning; 5 Warnings and Precautions.

## What else we have on pramlintide

### Pramlintide on PepVault

- [Pramlintide in the peptide library](https://pepvault.app/peptides/pramlintide)
- [Pramlintide: half-life](https://pepvault.app/peptides/pramlintide/half-life)
- [Pramlintide: side effects](https://pepvault.app/peptides/pramlintide/side-effects)
- [Pramlintide: how long it takes to work](https://pepvault.app/peptides/pramlintide/how-long-to-work)
- [Is Pramlintide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/pramlintide/legal-status)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

### Free tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003)

### Compound against compound

- [Cagrilintide vs Pramlintide](https://pepvault.app/peptides/compare/cagrilintide-vs-pramlintide)

## Questions about Symlin

### Is Symlin discontinued?

Drugs@FDA lists every Symlin product as discontinued, and its label’s product data gives January 31, 2027 as the end of marketing for both SymlinPen 60 and SymlinPen 120.

### What is the dose of Symlin?

In type 2 diabetes the label starts at 60 mcg before each main meal and moves to 120 mcg; in type 1 it starts at 15 mcg and rises in 15 mcg steps to 30, 45 or 60 mcg. A prescriber sets the dose and the insulin change that goes with it.

### Why is the insulin dose lowered when Symlin starts?

Symlin with insulin raises the risk of severe low blood sugar, so the label cuts the mealtime insulin by half at the start.

### What if a Symlin dose is missed?

It is not made up; the usual dose is taken before the next main meal.

### What is the most common side effect of Symlin?

Nausea: 48% in the type 1 trials against 17% on placebo, and 28% against 12% in type 2 on 120 mcg. It is usually worst at the start.

## Sources

- [SYMLIN (pramlintide acetate) injection for subcutaneous use, FDA label on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4aea30ff-eb0d-45c1-b114-3127966328ff) (version 18, published Aug 20, 2024; read Nov 18, 2026)
- [Drugs@FDA, NDA 021332](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021332) (Symlin, SymlinPen 60 and SymlinPen 120; application first approved 2005)

PepVault is not affiliated with AstraZeneca. Symlin is a trademark of its owner.

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## More on pramlintide

### Pramlintide on PepVault

- [Pramlintide in the peptide library](https://pepvault.app/peptides/pramlintide)
- [Pramlintide: half-life](https://pepvault.app/peptides/pramlintide/half-life)
- [Pramlintide: side effects](https://pepvault.app/peptides/pramlintide/side-effects)
- [Pramlintide: how long it takes to work](https://pepvault.app/peptides/pramlintide/how-long-to-work)
- [Is Pramlintide legal? FDA, DEA and WADA status](https://pepvault.app/peptides/pramlintide/legal-status)
- [Pramlintide dose guide](https://pepvault.app/lab/dosage/pramlintide)

### Free tools

- [Peptide half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The trials, in plain English

- [Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulin](https://pepvault.app/research/pramlintide-hollander-2003)

<!--promo-->

PepVault for iPhone

## Keep your own record in PepVault

Log each dose on your schedule, with a reminder for the next one.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=brand-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Brand-name drugs

- [Every brand, by ingredient](https://pepvault.app/drugs)

## The library

- [Pramlintide in the peptide library](https://pepvault.app/peptides/pramlintide)
- [The peptide reference library](https://pepvault.app/peptides)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. PepVault is not affiliated with AstraZeneca. Symlin is a trademark of its owner.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
